O3R-5671

N/A

Report date: 2025/10/20 14:18:35
NME

Base Information

Drug NameO3R-5671
Drug Alias NameO3R-5671
ClassificationOther
Mechanisms of ActionSalt-inducible kinase 3 inhibitors
TargetsSalt-inducible kinase 3
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesOnco3R Therapeutics BV
China Registration ClassN/A

Develop Information

Active CompaniesOnco3R Therapeutics BV
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A